Compare tool

BPC-157 vs TB-500 (Thymosin Beta-4)

Same attributes, same format, up to four peptides. Then let the advisor explain the trade-offs in plain language.

Peptide A

Bone, Joint & Connective Tissue

Peptide B

Cardiovascular & Pulmonary Health

Peptide C

Educational only, not medical advice.

AttributeBPC-157

Bone, Joint & Connective Tissue

TB-500 (Thymosin Beta-4)

Cardiovascular & Pulmonary Health

RouteSubcutaneous / Oral ResearchSubcutaneous
Dose range250 mcg – 1 mg500 mcg – 1 mg
FrequencyOnce or twice daily (subcutaneous).Once per day (subcutaneous).
TimingConsistent daily schedule; rotate injection sites.Any consistent time daily; rotate injection sites.
Cycle length8–12 weeks.8–12 weeks.
Vial options5 mg, 10 mg5 mg, 10 mg
Studied benefitsAccelerates healing in gut, tendon, muscle, and skin; possesses strong anti-inflammatory and cytoprotective properties.Promotes rapid wound healing, tissue repair, and the growth of new blood vessels (angiogenesis). It is widely used in research and veterinary settings to reduce inflammation and prevent excessive scar tissue (fibrosis) after injury.
Reported side effectsGood tolerability in early trials; side effects are primarily limited to mild injection-site redness or itching.Generally well-tolerated; human data is limited, but research settings report only occasional mild redness or tenderness at the injection site.
Cited studies97
N1 Aminosfrom $39.00 →

Code DOSING15 · 15% off first order

from $59.00 →

Code DOSING15 · 15% off first order

CalculatorDo the mathDo the math

AI explanation

Click “Explain the trade-offs” for a plain-language read on mechanism, dosing scale, side-effect profile and research depth.

BPC-157 vs TB-500 (Thymosin Beta-4)

Ask the advisor